Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
Fine-Tuning S1P Therapeutics.
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
PML risk stratification using anti-JCV antibody index and L-selectin.
Ten-year follow-up shows efficacy of Sanofi's MS drug Lemtrada
A phase-specific neuroimmune model of clinical depression.
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance.
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis.
Unmet education, psychological and peer support needs of people with multiple sclerosis.
Validation of a new quality of life scale related to multiple sclerosis and relapses.
Mixed Panniculitis Secondary to Interferon Beta-1a Therapy in a Woman With Multiple Sclerosis.
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.
Involvement and interplay of Parkin, PINK1 and DJ1 in neurodegenerative and neuroinflammatory disorders.
Expert recommendations to personalization of medical approaches in treatment of Multiple Sclerosis: an overview of family planning and pregnancy.
Reibergram and oligoclonal bands in diagnosis of multiple sclerosis.
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
The role of diet in multiple sclerosis.
Differentiation of neurosphere-derived rat neural stem cells into oligodendrocyte-like cells by repressing PDGF-α and Olig2 with triiodothyronine.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
The grey matter correlates of impaired decision-making in multiple sclerosis.
Detecting clinically-relevant changes in progressive multiple sclerosis.
Genetic targeting of microglia.
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex.
Pages
« first
‹ previous
…
256
257
258
259
260
261
262
263
264
…
next ›
last »